Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study

Background Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edema...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurology Vol. 272; no. 4; p. 306
Main Authors Paoletti, M., Monforte, M., Barzaghi, L., Tasca, G., Bergsland, N., Faggioli, A., Solazzo, F., Manco, G., Bortolani, S., Torchia, E., Ravera, B., Deligianni, X., Santini, F., Ballante, E., Figini, S., Tartaglione, T., Ricci, E., Pichiecchio, A.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.04.2025
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics. Methods Thirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline. Results The average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15–30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments. Conclusions Our longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects.
AbstractList Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics.BACKGROUNDFacioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics.Thirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline.METHODSThirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline.The average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15-30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments.RESULTSThe average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15-30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments.Our longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects.CONCLUSIONSOur longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects.
Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics. Thirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline. The average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15-30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments. Our longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects.
Background Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics. Methods Thirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline. Results The average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15–30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments. Conclusions Our longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects.
BackgroundFacioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics.MethodsThirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline.ResultsThe average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15–30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments.ConclusionsOur longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects.
ArticleNumber 306
Author Torchia, E.
Pichiecchio, A.
Ravera, B.
Santini, F.
Barzaghi, L.
Monforte, M.
Figini, S.
Tasca, G.
Manco, G.
Ricci, E.
Faggioli, A.
Tartaglione, T.
Bortolani, S.
Deligianni, X.
Bergsland, N.
Paoletti, M.
Solazzo, F.
Ballante, E.
Author_xml – sequence: 1
  givenname: M.
  surname: Paoletti
  fullname: Paoletti, M.
  organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation
– sequence: 2
  givenname: M.
  orcidid: 0000-0002-4327-6969
  surname: Monforte
  fullname: Monforte, M.
  email: mauro.monforte@policlinicogemelli.it
  organization: Dipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS
– sequence: 3
  givenname: L.
  surname: Barzaghi
  fullname: Barzaghi, L.
  organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation, INFN, Group of Pavia, Department of Mathematics, University of Pavia
– sequence: 4
  givenname: G.
  surname: Tasca
  fullname: Tasca, G.
  organization: John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trusts
– sequence: 5
  givenname: N.
  surname: Bergsland
  fullname: Bergsland, N.
  organization: Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, University of Buffalo, the State University of New York, IRCCS, Fondazione Don Carlo Gnocchi ONLUS
– sequence: 6
  givenname: A.
  surname: Faggioli
  fullname: Faggioli, A.
  organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation
– sequence: 7
  givenname: F.
  surname: Solazzo
  fullname: Solazzo, F.
  organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation
– sequence: 8
  givenname: G.
  surname: Manco
  fullname: Manco, G.
  organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation
– sequence: 9
  givenname: S.
  surname: Bortolani
  fullname: Bortolani, S.
  organization: Dipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS
– sequence: 10
  givenname: E.
  surname: Torchia
  fullname: Torchia, E.
  organization: Università Cattolica del Sacro Cuore
– sequence: 11
  givenname: B.
  surname: Ravera
  fullname: Ravera, B.
  organization: Università Cattolica del Sacro Cuore
– sequence: 12
  givenname: X.
  surname: Deligianni
  fullname: Deligianni, X.
  organization: Department of Radiology, University Hospital Basel, Department of Biomedical Engineering, Basel Muscle MRI, University of Basel
– sequence: 13
  givenname: F.
  surname: Santini
  fullname: Santini, F.
  organization: Department of Radiology, University Hospital Basel, Department of Biomedical Engineering, Basel Muscle MRI, University of Basel
– sequence: 14
  givenname: E.
  surname: Ballante
  fullname: Ballante, E.
  organization: Department of Political and Social Sciences, University of Pavia, BioData Science Center, IRCCS Mondino Foundation
– sequence: 15
  givenname: S.
  surname: Figini
  fullname: Figini, S.
  organization: Department of Political and Social Sciences, University of Pavia, BioData Science Center, IRCCS Mondino Foundation
– sequence: 16
  givenname: T.
  surname: Tartaglione
  fullname: Tartaglione, T.
  organization: Università Cattolica del Sacro Cuore, Istituto Dermopatico Dell’Immacolata (IDI), IRCCS
– sequence: 17
  givenname: E.
  surname: Ricci
  fullname: Ricci, E.
  organization: Dipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore
– sequence: 18
  givenname: A.
  surname: Pichiecchio
  fullname: Pichiecchio, A.
  organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation, Department of Brain and Behavioural Sciences, University of Pavia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40172709$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhS1URKeFP8ACWWLDJuBHHDtsEKooVCogIVhbd2ynSZXEqR8jZc0frztTymPBypbPd67vtc8JOpr97BB6TslrSoh8EwmpqagIExXlpGGVeoQ2tOasorVoj9CG8JpUgov6GJ3EeE0IUUV4go5rQiWTpN2gn18g5QAj7oeYfFix73AHZvDRwJJH3-fJ3clTjiaPELBdYwp-6VfsdjBmSM7i7Vr0MQ0LBJhcCoPBNxnmNCRIw87hz98u3mLAS_BxcWZ_ZHzvQ8IxZbs-RY87GKN7dr-eoh_nH76ffaouv368OHt_WZmaqVQZyVvpHHRWMihbxu1WdS2VlklVW8m5taITyjRWkRYs441UxChQYFXTOH6K3h3qLnk7OWvcnMpoegnDBGHVHgb9tzIPvb7yO01p2wjWsFLh1X2F4G-yi0lPQzRuHGF2PkfNqRKMCtG0BX35D3rtc5jLfHtKEEEIL9SLP1t66OXXBxWAHQBTHi8G1z0glOi7FOhDCnRJgd6nQKti4gdTLPB85cLvu__jugWD47hz
Cites_doi 10.1016/j.nmd.2019.08.011
10.1002/jcsm.12555
10.1007/s12035-017-0563-x
10.1002/ana.24640
10.1002/jcsm.13250
10.3389/fneur.2021.630387
10.1002/jmri.24619
10.3389/fneur.2021.749736
10.1093/hmg/ddaa031
10.1007/s10334-021-00967-4
10.1212/WNL.0000000000010155
10.48550/arXiv.2302.06352
10.1002/mus.23911
10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M
10.1212/WNL.0000000000200757
10.1038/s43856-022-00217-1
10.1038/s41598-024-65802-x
10.1016/j.nmd.2022.10.005
10.1371/journal.pone.0038779
10.1007/s00415-022-11336-z
10.1371/journal.pone.0183825
10.1002/jcsm.12343
10.3389/fneur.2019.00078
10.1109/EMBC.2016.7591443
10.1007/s00415-016-8361-3
10.1007/s00415-021-10786-1
10.1212/CON.0000000000001155
10.1186/s12891-021-04134-7
10.1007/s00330-020-07487-0
10.1016/j.nmd.2025.105274
10.3233/JND-240053
10.1007/s00415-019-09242-y
10.1097/WCO.0000000000001305
10.1093/hmg/ddy364
10.1212/WNL.0000000000004647
10.1002/jcsm.12473
10.1212/WNL.0000000000002640
10.1002/nbm.5214
10.3233/JND-160145
10.1002/jmri.24613
10.3389/fneur.2021.675781
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
Copyright Springer Nature B.V. Apr 2025
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: Copyright Springer Nature B.V. Apr 2025
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
7X8
5PM
DOI 10.1007/s00415-025-13062-8
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1459
ExternalDocumentID PMC11965262
40172709
10_1007_s00415_025_13062_8
Genre Journal Article
GrantInformation_xml – fundername: Ministero della Salute
  grantid: RF-2016-02362914
  funderid: http://dx.doi.org/10.13039/501100003196
– fundername: Università Cattolica del Sacro Cuore
– fundername: Ministero della Salute
  grantid: RF-2016-02362914
GroupedDBID ---
-Y2
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
28-
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3SX
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHIR
ADHKG
ADIMF
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDYV
AFDZB
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGVAE
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
AYFIA
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PHGZT
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
X7M
YLTOR
Z45
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AAYXX
ABFSG
ACSTC
AEZWR
AFHIU
AFOHR
AHWEU
AIXLP
ATHPR
CITATION
PHGZM
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
7X8
5PM
ID FETCH-LOGICAL-c428t-c7397eeafd72a39723db8f917d2784d733dd5f58c6d809ad236780c8a8ad866e3
IEDL.DBID U2A
ISSN 0340-5354
1432-1459
IngestDate Thu Aug 21 18:37:50 EDT 2025
Fri Jul 11 18:50:54 EDT 2025
Fri Jul 25 22:46:24 EDT 2025
Mon Jul 21 05:41:54 EDT 2025
Sun Jul 06 05:09:04 EDT 2025
Sat Apr 19 01:11:19 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Fat fraction
WT2
QMRI
Imaging
FSHD
Muscle
Quantitative MRI
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c428t-c7397eeafd72a39723db8f917d2784d733dd5f58c6d809ad236780c8a8ad866e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4327-6969
OpenAccessLink https://link.springer.com/10.1007/s00415-025-13062-8
PMID 40172709
PQID 3185505003
PQPubID 47196
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11965262
proquest_miscellaneous_3185215569
proquest_journals_3185505003
pubmed_primary_40172709
crossref_primary_10_1007_s00415_025_13062_8
springer_journals_10_1007_s00415_025_13062_8
PublicationCentury 2000
PublicationDate 2025-04-01
PublicationDateYYYYMMDD 2025-04-01
PublicationDate_xml – month: 04
  year: 2025
  text: 2025-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle Journal of neurology
PublicationTitleAbbrev J Neurol
PublicationTitleAlternate J Neurol
PublicationYear 2025
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References JW Chardon (13062_CR3) 2019; 29
SCC Vincenten (13062_CR18) 2023; 14
M Paoletti (13062_CR40) 2021; 12
M Monforte (13062_CR13) 2019; 10
F Santini (13062_CR28) 2021; 12
C Nuñez-Peralta (13062_CR29) 2020; 11
H Reyngoudt (13062_CR34) 2021; 31
M Weigel (13062_CR27) 2015; 41
A Alonso-Jiménez (13062_CR33) 2021; 12
ML Mellion (13062_CR20) 2022; 99
PA Yushkevich (13062_CR25) 2016; 2016
G Tasca (13062_CR12) 2016; 79
JR Dahlqvist (13062_CR37) 2019; 266
JR Dahlqvist (13062_CR19) 2020; 95
A Agosti (13062_CR23) 2021; 35
E Vegezzi (13062_CR39) 2023; 270
PG Carlier (13062_CR5) 2016; 3
L Heskamp (13062_CR35) 2022; 2
13062_CR24
C Bolano-Díaz (13062_CR2) 2024; 37
N Azzabou (13062_CR30) 2015; 41
J Forsting (13062_CR41) 2024; 37
M Monforte (13062_CR31) 2021; 269
SCC Vincenten (13062_CR36) 2025; 47
M Paoletti (13062_CR6) 2019; 10
SD Friedman (13062_CR11) 2014; 49
G Tasca (13062_CR8) 2012; 7
K Mul (13062_CR1) 2022; 28
B Janssen (13062_CR15) 2016; 86
F Fatehi (13062_CR17) 2017; 12
13062_CR26
L Schlaffke (13062_CR38) 2024; 11
K Mul (13062_CR21) 2017; 89
L Riem (13062_CR32) 2024; 14
LH Wang (13062_CR16) 2021; 22
M Monforte (13062_CR4) 2022; 33
C-J Wong (13062_CR7) 2020; 29
G Tasca (13062_CR10) 2018; 55
A Grimm (13062_CR42) 2018; 9
LH Wang (13062_CR9) 2019; 28
G Andersen (13062_CR14) 2017; 264
E Ricci (13062_CR22) 1999; 45
References_xml – volume: 29
  start-page: 827
  year: 2019
  ident: 13062_CR3
  publication-title: Neuromuscul Disord
  doi: 10.1016/j.nmd.2019.08.011
– volume: 11
  start-page: 1032
  year: 2020
  ident: 13062_CR29
  publication-title: J Cachexia Sarcopenia Muscle
  doi: 10.1002/jcsm.12555
– volume: 55
  start-page: 2959
  year: 2018
  ident: 13062_CR10
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-017-0563-x
– volume: 79
  start-page: 854
  year: 2016
  ident: 13062_CR12
  publication-title: Ann Neurol
  doi: 10.1002/ana.24640
– volume: 14
  start-page: 1695
  year: 2023
  ident: 13062_CR18
  publication-title: J Cachexia Sarcopenia Muscle
  doi: 10.1002/jcsm.13250
– volume: 12
  year: 2021
  ident: 13062_CR28
  publication-title: Front Neurol
  doi: 10.3389/fneur.2021.630387
– ident: 13062_CR26
– volume: 41
  start-page: 266
  year: 2015
  ident: 13062_CR27
  publication-title: J Magn Reson Imaging JMRI
  doi: 10.1002/jmri.24619
– volume: 12
  year: 2021
  ident: 13062_CR40
  publication-title: Front Neurol
  doi: 10.3389/fneur.2021.749736
– volume: 29
  start-page: 1030
  year: 2020
  ident: 13062_CR7
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddaa031
– volume: 35
  start-page: 467
  year: 2021
  ident: 13062_CR23
  publication-title: Magn Reson Mater Phys Biol Med
  doi: 10.1007/s10334-021-00967-4
– volume: 95
  start-page: e1211
  year: 2020
  ident: 13062_CR19
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000010155
– ident: 13062_CR24
  doi: 10.48550/arXiv.2302.06352
– volume: 49
  start-page: 257
  year: 2014
  ident: 13062_CR11
  publication-title: Muscle Nerve
  doi: 10.1002/mus.23911
– volume: 45
  start-page: 751
  year: 1999
  ident: 13062_CR22
  publication-title: Ann Neurol
  doi: 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M
– volume: 99
  start-page: e877
  year: 2022
  ident: 13062_CR20
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000200757
– volume: 2
  start-page: 155
  year: 2022
  ident: 13062_CR35
  publication-title: Commun Med
  doi: 10.1038/s43856-022-00217-1
– volume: 14
  start-page: 15462
  year: 2024
  ident: 13062_CR32
  publication-title: Sci Rep
  doi: 10.1038/s41598-024-65802-x
– volume: 33
  start-page: 65
  year: 2022
  ident: 13062_CR4
  publication-title: Neuromuscul Disord
  doi: 10.1016/j.nmd.2022.10.005
– volume: 7
  year: 2012
  ident: 13062_CR8
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0038779
– volume: 270
  start-page: 328
  year: 2023
  ident: 13062_CR39
  publication-title: J Neurol
  doi: 10.1007/s00415-022-11336-z
– volume: 12
  year: 2017
  ident: 13062_CR17
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0183825
– volume: 9
  start-page: 1093
  year: 2018
  ident: 13062_CR42
  publication-title: J Cachexia Sarcopenia Muscle
  doi: 10.1002/jcsm.12343
– volume: 10
  start-page: 78
  year: 2019
  ident: 13062_CR6
  publication-title: Front Neurol
  doi: 10.3389/fneur.2019.00078
– volume: 2016
  start-page: 3342
  year: 2016
  ident: 13062_CR25
  publication-title: Conf Proc Annu Int Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol Soc Annu Conf
  doi: 10.1109/EMBC.2016.7591443
– volume: 264
  start-page: 438
  year: 2017
  ident: 13062_CR14
  publication-title: J Neurol
  doi: 10.1007/s00415-016-8361-3
– volume: 269
  start-page: 2055
  year: 2021
  ident: 13062_CR31
  publication-title: J Neurol
  doi: 10.1007/s00415-021-10786-1
– volume: 28
  start-page: 1735
  year: 2022
  ident: 13062_CR1
  publication-title: Contin Minneap Minn
  doi: 10.1212/CON.0000000000001155
– volume: 22
  start-page: 262
  year: 2021
  ident: 13062_CR16
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/s12891-021-04134-7
– volume: 31
  start-page: 4264
  year: 2021
  ident: 13062_CR34
  publication-title: Eur Radiol
  doi: 10.1007/s00330-020-07487-0
– volume: 47
  year: 2025
  ident: 13062_CR36
  publication-title: Neuromuscul Dis
  doi: 10.1016/j.nmd.2025.105274
– volume: 11
  start-page: 997
  year: 2024
  ident: 13062_CR38
  publication-title: J Neuromuscul Dis
  doi: 10.3233/JND-240053
– volume: 266
  start-page: 1127
  year: 2019
  ident: 13062_CR37
  publication-title: J Neurol
  doi: 10.1007/s00415-019-09242-y
– volume: 37
  start-page: 536
  year: 2024
  ident: 13062_CR2
  publication-title: Curr Opin Neurol
  doi: 10.1097/WCO.0000000000001305
– volume: 28
  start-page: 476
  year: 2019
  ident: 13062_CR9
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddy364
– volume: 89
  start-page: 2057
  year: 2017
  ident: 13062_CR21
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000004647
– volume: 10
  start-page: 1258
  year: 2019
  ident: 13062_CR13
  publication-title: J Cachexia Sarcopenia Muscle
  doi: 10.1002/jcsm.12473
– volume: 86
  start-page: 1700
  year: 2016
  ident: 13062_CR15
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000002640
– volume: 37
  year: 2024
  ident: 13062_CR41
  publication-title: NMR Biomed
  doi: 10.1002/nbm.5214
– volume: 3
  start-page: 1
  year: 2016
  ident: 13062_CR5
  publication-title: J Neuromuscul Dis
  doi: 10.3233/JND-160145
– volume: 41
  start-page: 645
  year: 2015
  ident: 13062_CR30
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.24613
– volume: 12
  year: 2021
  ident: 13062_CR33
  publication-title: Front Neurol
  doi: 10.3389/fneur.2021.675781
SSID ssj0008459
Score 2.4486027
Snippet Background Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle...
Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic...
BackgroundFacioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 306
SubjectTerms Adult
Aged
Cohort analysis
Cohort Studies
Disease Progression
Edema
Edema - diagnostic imaging
Female
Genetic disorders
Humans
Longitudinal Studies
Magnetic Resonance Imaging
Male
Medicine
Medicine & Public Health
Middle Aged
Multiparametric Magnetic Resonance Imaging - methods
Muscle, Skeletal - diagnostic imaging
Muscle, Skeletal - pathology
Muscular dystrophy
Muscular Dystrophy, Facioscapulohumeral - diagnostic imaging
Muscular Dystrophy, Facioscapulohumeral - pathology
Muscular Dystrophy, Facioscapulohumeral - physiopathology
Neurology
Neuroradiology
Neurosciences
Original Communication
Prospective Studies
Skeletal muscle
Water content
Title Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study
URI https://link.springer.com/article/10.1007/s00415-025-13062-8
https://www.ncbi.nlm.nih.gov/pubmed/40172709
https://www.proquest.com/docview/3185505003
https://www.proquest.com/docview/3185215569
https://pubmed.ncbi.nlm.nih.gov/PMC11965262
Volume 272
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB7RVkJcEAUKgRJtpd6KJWcf9pZbGjUUUHJAjdSerMnuWq1U7JLYh5z548yuHygtHJAs-bAjr3dndjzjmfkG4JijROVSFQlSBOSguDxCbqVHwlRmpLXjAV1_Nk8uFvLrlbpqi8LWXbZ7F5IMmrovdvPQUL6aWEWkdxM6xzuwp7zvTlK84ONe_2oZWqTFQsaREkq2pTJ_f8b25-iRjfk4VfJBvDR8hqYv4HlrP7Jxw_B9eOKKl_B01kbIX8GvOQYkDdYACW9YmbMczW25Nnhf35U3dfgLxX7UTQYqs5t1tSpps1kL_O0sW25Yk2iIPnXLY_iznzUWoR6NtCObff_yiSGjdXSFmsw32l1VLKDVvobF9PxychG1jRYiQ95HFZmUrBLnMLcpR-H7kNmlzsmRsz4saVMhrFW50iaxOj5F61HfdGw0arQ6SZw4gN2iLNxbYGhHPBbC0eVkzi1qq4QxUmBK5PnpAE66_c7uGzyNrEdODtzJiDtZ4E6mB3DYsSRrz9Y68_XeZLeROhrAUT9Mp8KHOrBwZd3QkDGjEprwTcPBfjrp3d40phG9xduewCNub48UtzcBeXvk8Rd5wgfwsRODP-_172W8-z_y9_CMexEN-UGHsFutaveBTJ9qOYS98fTsbO7vn6-_nQ9hZ5JMhkH-fwMrsAKo
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB5RkNpeEPQBWx51pd7aSFk_EsMNrUDLY_dQgcQtmrUdgQQJ7CaHPfePd-xkgxbKASm3GcWxxx7PZGa-AfjJUaJyqYoEKQJyUFweIbfSI2Eq09fa8YCuPxonwyt5dq2uW5gcXwvzLH4fwD77voZYRaRtEzq972BNkqfs0_cGyaDTulqGxmixkHGkhJJtgcz_37F8Cb2wLF8mSD6LkobL52QD1lurkR01Yt6EFVd8gvejNi7-Gf6OMeBnsAY-eM7KnOVobsuZwYf6rrypw78ndl83eafMzmfVtKQlZi3ct7NsMmdNeiH6hC2P3M8eayxCFRrpRDb6c3rIkNE8FuWZzLfXnVYsYNR-gauT48vBMGrbK0SGfI4qMinZIs5hblOOwncfsxOdk_tmfTDSpkJYq3KlTWJ1fIDWY73p2GjUaHWSOPEVVouycNvA0PZ5LISjx8mcW9RWCWOkwJTY84Me_Fqsd_bQoGhkHV5ykE5G0smCdDLdg92FSLL2RM0yX-VN1hopoR786Mh0FnyAAwtX1g0PmTAqoQG3Ggl2w0nv7KYxUfSSbDsGj7O9TClubwLedt-jLvKE9-D3Yhs8fdfr0_j2Nvbv8GF4ObrILk7H5zvwkfvtGjKEdmG1mtZuj4yfarIfdv0_vlT9fg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkSouiPLqQgtG4gZRs34kLrdqy6oFdoUQlXqLZv1QK0Gy7CaHPfPHGTsPWAoHpNw8imOPPZ7JzPcZ4BVHicrlKhFkCChAcT5BbmVgwlRmrLXjkV1_Ns_OLuT7S3X5G4o_Vrv3KckW0xBYmsr6aGn90QB8CzRRAVmsErLBGe3p23CHIpWYqJ1kk8EWaxmvS0uFTBMllOxgM39_x_bRdMPfvFk2-UfuNB5J0_twr_Ml2Umr_D245coHsDvrsuUP4cccI6sGa0mFN6zyzKO5rtYGl83X6qqJf6TYt6atRmV2s65XFU0860jAnWWLDWuLDjGUcQU-f_a9wTJi08hSstnn87cMGY2jB22ycOnuqmaRufYRXEzffZmcJd2lC4mhSKROTE4einPobc5RhDvJ7EJ7CupsSFHaXAhrlVfaZFanx2gDA5xOjUaNVmeZE49hp6xKtw8M7ZinQjh6nPTcorZKGCMF5iTuj0fwup_vYtlyaxQDi3LUTkHaKaJ2Cj2Cg14lRbfP1kXAfpMPR6ZpBC-HZtohIe2BpauaVoYcG5VRh09aDQ7dyRAC5ym16C3dDgKBfXu7pby-iizc48DFyDM-gjf9Mvj1Xf8extP_E38Bu59Op8XH8_mHZ3CXh9Uay4YOYKdeNe6QPKJ68Twu-p-b_gXU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Natural+history+of+facioscapulohumeral+muscular+dystrophy+evaluated+by+multiparametric+quantitative+MRI%3A+a+prospective+cohort+study&rft.jtitle=Journal+of+neurology&rft.au=Paoletti%2C+M&rft.au=Monforte%2C+M&rft.au=Barzaghi%2C+L&rft.au=Tasca%2C+G&rft.date=2025-04-01&rft.eissn=1432-1459&rft.volume=272&rft.issue=4&rft.spage=306&rft_id=info:doi/10.1007%2Fs00415-025-13062-8&rft_id=info%3Apmid%2F40172709&rft.externalDocID=40172709
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5354&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5354&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5354&client=summon